Introduction
============

Mindfulness has been described in clinical contexts as paying attention in a purposeful way to the present moment, without judgment ([@B3]). In adults, mindfulness-based interventions (MBIs) have been utilized for managing common, chronic health conditions like type 2 diabetes (T2D). Randomized controlled trials in adults with diabetes show that MBIs have small-to-moderate effects for decreasing depression and heterogeneous effects for glycemic control ([@B1]). MBIs are designed to address depression by increasing frequency of mindful states, thereby providing individuals with more effective ways of coping with stressors that accompany major health conditions.

Learning mindfulness-based coping skills during adolescence has potential to alter progression of metabolic abnormalities. In particular, adolescence is a sensitive period for insulin resistance (IR) that accompanies puberty. Pubertal IR triggers a trajectory toward worsening IR and eventual T2D in vulnerable youth ([@B4]). Adolescents at-risk for T2D are disproportionately female, from historically marginalized race/ethnicities, and frequently experience depression ([@B12]). Depression symptoms are associated with greater IR in adolescents, predict worsening IR over time, and relate to T2D onset in young adulthood ([@B8]; [@B9]). Depression is hypothesized to affect IR, independent of energy balance, through stress-related behavior (e.g., emotional-eating) and physiology (e.g., hypercortisolism). Therefore, intervening to increase mindfulness and decrease depression in adolescents at-risk for T2D is anticipated to ameliorate IR. MBIs may have salutary effects on IR through a number of mechanisms, including decreases in depression and increases in effective self-regulation of attention, stress, emotion, and behaviors important for IR, such as emotional eating ([@B6]).

We conducted a randomized, controlled trial to pilot an MBI in adolescent girls at-risk for T2D with elevated depression symptoms. We had positive findings for the primary outcome of feasibility/acceptability ([@B7]). In secondary analyses, we found that adolescents in MBI had larger post-treatment decreases in depression and IR and larger 6-month decreases in depression, compared to cognitive-behavioral therapy (CBT; [@B7]).

The objective of this brief report was to explore 1-year outcomes. We hypothesized that adolescents randomized to MBI would have lower depression and IR at 1-year than CBT participants, based upon our initial findings and the notion that MBI may be uniquely suited for the high-stress arousal and psychosocial context of adolescents at-risk for T2D ([@B7]). In contrast to CBT depression interventions that focus on restructuring negative thoughts and increasing positive behaviors, MBI centers on cultivating self-regulation through present-focused, non-judgmental attention to one's body, emotions, and thoughts. The current analysis directly addresses shortcomings of existing literature by relying on a randomized controlled design, using an active comparator, and conducting long-term follow-up ([@B11]).

Methods
=======

Participants and Procedures
---------------------------

Adolescents were recruited for a prevention of T2D pilot trial, conducted at an academic setting in the western region of the United States between January 2014--August 2016 ([ClinicalTrials.gov](http://clinicaltrials.gov): NCT02218138). Participants were girls, mean ± SD~age~ 14.99 ± 1.69y (Range 12--17y) of all racial/ethnic backgrounds (70% non-Hispanic White, 21% Hispanic, 9% American Indian) predisposed to elevated IR by overweight/obesity (BMI ≥ 85th percentile) and T2D family history. The Institutional Review Board of Colorado State University approved all procedures. Youth had elevated depression, based on a total score ≥ 16 on the Center for Epidemiologic Studies-Depression Scale (CES-D~totalscore~ 25.27 ± 6.63). Baseline exclusion criteria were pregnancy, major depressive disorder or diagnosis warranting treatment, major medical problem (e.g., T2D), medication affecting mood/insulin, or psychotherapy. Parental guardians provided written informed consent, and adolescents gave written assent, after having the study described to them in detail.

Following an appointment to screen eligibility and collect baseline assessments, adolescents were randomized to a six-session MBI group (Learning to BREATHE; *n* = 17) or six-session CBT depression prevention group (Blues Program; *n* = 15) ([@B7]). The randomization sequence was generated by an electronic program using permuted blocks and stratified by age and race/ethnicity. Interventions were matched for time and attention. Sessions were co-facilitated by a clinical psychologist and graduate student in psychology or marriage and family therapy. Phlebotomists were blinded to allocation; trained research associates or graduate research assistants served as assessors of psychosocial characteristics and body measurements, and they were not consistently blinded.

Measures
--------

For the current brief report, measures collected at baseline and 1-year were evaluated. The CES-D measured depression symptoms and the Mindful Attention Awareness Scale (MAAS) assessed basic dispositional mindfulness. IR was estimated with homeostasis model assessment of IR (HOMA-IR), a surrogate with good convergent validity with hyperinsulinemic euglycemic clamp-derived measures ([@B2]). Adiposity was measured as percentage total fat-mass from dual-energy x-ray absorptiometry. Tanner-breast stage was self-reported. BMI-metrics were determined from fasting weight/height according to Centers for Disease Control and Prevention 2000 standards.

Analytic Plan
-------------

A pilot sample size of *n* = 15--25 per arm is recommended for informing a main trial in which small-to-moderate standardized effects are anticipated ([@B13]). All variables approximated a normal distribution. Using IBM SPSS Statistics 25, EM (expectation--maximation) was used to impute missing data. Univariate ANCOVA with the intent-to-treat sample was used to evaluate condition (MBI vs. CBT) as a predictor of baseline-to-1-year change in depression and IR. Covariates were race/ethnicity, baseline level of each outcome, age, weight status (overweight BMI 85th--94th percentile vs. obesity BMI ≥ 95th percentile), puberty (Tanner 5 reported breast development vs. Tanner 3--4), adiposity, and 1-year adiposity change. ANCOVA also was used to describe between-condition and within-condition differences in baseline-to-1-year change in dispositional mindfulness, BMI indices, and adiposity. In addition to statistical significance (*p* \< 0.05), we estimated effect size with Cohen's *d* (small: 0.2, medium: 0.5, large ≥ 0.8).

Results
=======

Descriptive information on baseline and 1-year sample characteristics is provided in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}. One-year retention was 71% (*n* = 12) in MBI; 81% (*n* = 13) in CBT (*p* = 0.48). Baseline characteristics were not significantly related to retention.

[Table 1](#T1){ref-type="table"} summarizes baseline-to-1-year changes by condition, accounting for covariates. Depression decreased from baseline-to-1-year within MBI and CBT, with a greater decrease in MBI (*d* = −0.68, *p* = 0.03; [Figure 1](#F1){ref-type="fig"}). Adolescents in MBI decreased baseline-to-1-year IR compared to stable IR in CBT, with a moderate, between-condition effect size(*d* = 0.73, *p* \< 0.01).

###### 

Summary of univariate analyses of covariance (ANCOVA) predicting change in outcome from group condition.

  Baseline to 1-year change   MBI^‡^                      CBT^‡^                    Between-group effect^‡^   *p*-value   Cohen's *d* effect size
  --------------------------- --------------------------- ------------------------- ------------------------- ----------- -------------------------
  Depression symptoms         −14.17 \[−18.23, −10.12\]   −7.65 \[−11.67, −3.63\]   −6.52 \[−12.22, −0.82\]   0.03        0.68
  Insulin resistance          −1.26 \[−2.07, −0.44\]      0.57 \[−0.22, 1.36\]      −1.83 \[−2.92, −0.73\]    \<0.01      0.73
  Dispositional mindfulness   0.53 \[0.14, 0.93\]         0.38 \[−0.01, 0.77\]      0.16 \[−0.38, 0.69\]      0.55        0.17
  Body fat (%)                −2.01 \[−3.93, −0.10\]      −1.31 \[−3.21, 0.58\]     −0.70 \[−3.34, 1.94\]     0.59        0.18
  BMI (kg/m^2^)               −0.43 \[−1.57, 0.71\]       0.40 \[−0.67, 1.48\]      −0.83 \[−2.36, 0.70\]     0.27        0.44
  BMI, *z*-score              −0.16 \[−0.30, −0.03\]      −0.10 \[−0.24, 0.03\]     −0.06 \[−0.24, 0.13\]     0.54        0.25

‡

Mean \[95% CI\]. MBI, mindfulness-based intervention, n = 17. CBT, cognitive-behavioral therapy, n = 16. BMI, body mass index. Analyses predicting mindfulness, depression, and insulin resistance accounted for race/ethnicity, baseline level of the outcome, baseline age, baseline weight status (overweight BMI 85th--94th percentile vs. obesity BMI ≥ 95th percentile), baseline puberty (Tanner 5 reported breast development vs. Tanner 3--4). Analyses predicting body fat and BMI indices accounted for race/ethnicity, baseline level of the outcome, baseline age, baseline weight status, and baseline puberty.

![Baseline to 1-year change (Mean, SE) in **(A)** depression symptoms, **(B)** homeostasis model assessment of insulin resistance (HOMA-IR), **(C)** dispositional mindfulness, **(D)** adiposity (%), **(E)** body mass index (BMI; k/gm^2^), and **(F)** BMI *z*-score by condition: MBI (mindfulness-based group intervention; *n* = 17) vs. CBT (cognitive-behavioral therapy; *n* = 16) group intervention. *P*-values refer to the between-group difference in baseline to 1-year change, derived from univariate analyses of covariance (ANCOVA) using the intent-to-treat sample with EM (expectation--maximation) to handle missing data. Models a, b, and c accounted for race/ethnicity, baseline level of the outcome, baseline age, baseline weight status (overweight BMI 85th--94th percentile vs. obesity BMI ≥ 95th percentile), baseline puberty (Tanner 5 reported breast development vs. Tanner 3--4), baseline adiposity, and 1-year change in adiposity. Models d and e accounted for race/ethnicity, baseline level of the outcome, baseline age, baseline weight status, and baseline puberty.](fpsyg-10-01040-g001){#F1}

There were no other between-condition differences. Mindfulness increased from baseline-to-1-year within MBI, with no within-group change in CBT (*d*~between--group~ = 0.17, *p* = 0.55). Adiposity decreased within MBI, with no change within CBT (*d*~between--group~ = 0.18, *p* = 0.59). Likewise, BMI *z*-score decreased within MBI, with no change within CBT (*d*~between--group~ = 0.25, *p* = 0.54). BMI raw-score change was stable within both conditions (*d*~between--group~ = 0.44, *p* = 0.27).

Discussion
==========

Consistent with previous findings ([@B7]), adolescents at-risk for T2D with elevated depression had greater decreases in depression symptoms 1-year following a six-session MBI, as compared to adolescents who were randomized to CBT. Yet, adolescents in both conditions significantly decreased depression symptoms. Additionally, even after accounting for change in adiposity, we observed a moderate between-condition effect for MBI in reducing 1-year IR, as compared to stable IR in CBT. To our knowledge, this is the first randomized controlled trial to pilot a comparison of MBI and CBT in adolescents. In adults with vascular disease, MBIs have consistently shown greater decreases in depression symptoms as compared to a control condition ([@B1]), but equivocal effects for decreasing depression as compared to CBT ([@B10]).

In this pilot study, dispositional mindfulness increased at 1-year within MBI only, but the between-condition difference was a non-significant, small effect relative to CBT. One possibility is that by more effectively decreasing depression, MBI improves underlying behavioral and/or physiological factors that affect IR such as sleep, physical activity, eating behavior, and stress arousal. A significant limitation is the pilot nature of the current study; the small sample size warrants caution regarding interpretation of effect sizes ([@B5]). Provided replication with a larger sample, the current findings suggest there may be promise for relatively brief MBI approaches to lessen T2D risk in adolescents with depression. Differentiating mechanisms of MBI vs. CBT in adolescents at-risk for T2D is an important step for future research. Pinpointing mechanisms would help to refine theoretical models and ultimately, aid in developing scalable integrative health interventions for this group of at-risk adolescents.
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